The Deal
Wednesday, November 25, 
1:00 am

Entries tagged "Enfamil"

Enfamil IPO to make Bristol-Myers easier to swallow?

As rival pharmaceutical companies begin to pair up, Bristol-Myers Squibb prepares to unload its children's nutrition unit Mead Johnson.


Could Nestle's Alcon sale beget more deals?

Nestle SA's sale of a 25% stake in eye-care company Alcon Inc. for $11 billion could give the acquisitive Swiss consumer products giant ammunition for more deals. With some notable consumer product businesses on the auction block, Nestle would have some high-profile brands to buy....


Bristol Myers tests the thirst for Enfamil auction

Three months after announcing a strategic review of its Mead Johnson baby formula unit, pharmaceutical giant Bristol-Myers Squibb reportedly has ratcheted up the sale process. Bristol Myers, which is asking $7 billion to $9 billion for the unit best known for the Enfamil brand, reportedly has contacted food giants PepsiCo, Danone, Nestlé, Kraft and Heinz, and pharma rivals Johnson & Johnson, GlaxoSmithKline and Novartis, the Financial Times said. ...



Top tags

You have executed a tag search on Dealscape. On the left,you will find a comprehensive list of stories tagged "Enfamil." Below are the most-popular tags for Dealscape. On the right of the page you will find a search box to dig deeper into our content.
The Deal Pipeline

Deal Video


Inside The Deal: Cisco Systems' Ned Hooper on raising the bid for Tandberg.

More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

REIT IPO deja vu

By Edward Schneidman, Michael Blair and David Malinger, Mayer Brown

Real estate sponsors that might wish to undertake an IPO will need to consider a wide variety of issues and begin to take action long before the first filing with the SEC.


Industry Insight

Loan-to-buy

By Steven Miller, Standard & Poor's

Paulson's proposal to purchase an equity stake in Yellow Pages publisher Idearc is the second time in recent months an investor group has used its prepetition debt position to execute a bargain price 'exit LBO.'


Industry Insight

Managing your shareholder base

By Bradford P. Weirick and Joelle Khoury, Gibson Dunn

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.



©Copyright 2008, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.